Document is current
Any future updates will be listed below
-
Authors
Grove, Jane I. https://orcid.org/0000-0002-9950-7201
Stephens, Camilla https://orcid.org/0000-0002-0796-9610
Lucena, M. Isabel https://orcid.org/0000-0001-9586-4896
Andrade, Raúl J. https://orcid.org/0000-0002-1565-0757
Weber, Sabine
Gerbes, Alexander https://orcid.org/0000-0003-0440-7417
Bjornsson, Einar S. https://orcid.org/0000-0002-8392-0632
Stirnimann, Guido https://orcid.org/0000-0003-3447-264X
Daly, Ann K. https://orcid.org/0000-0002-7321-0629
Hackl, Matthias https://orcid.org/0000-0002-4136-7293
Khamina-Kotisch, Kseniya https://orcid.org/0000-0002-7363-7905
Marin, Jose J. G.
Monte, Maria J. https://orcid.org/0000-0003-1844-7428
Paciga, Sara A. https://orcid.org/0000-0002-2495-5982
Lingaya, Melanie https://orcid.org/0000-0002-9390-2315
Forootan, Shiva S.
Goldring, Christopher E. P.
Poetz, Oliver
Lombaard, Rudolf
Stege, Alexandra https://orcid.org/0000-0001-9659-1930
Bjorrnsson, Helgi K.
Robles-Diaz, Mercedes https://orcid.org/0000-0002-2365-2787
Li, Dingzhou
Tran, Thi Dong Binh
Ramaiah, Shashi K.
Samodelov, Sophia L. https://orcid.org/0000-0003-1955-6060
Kullak-Ublick, Gerd A. https://orcid.org/0000-0002-0757-4408
Aithal, Guruprasad P. https://orcid.org/0000-0003-3924-4830
,
-
Funding
Funding for this research was provided by:
NIHR Nottingham Biomedical Research Centre (BRC-1215-20003, NIHR203310)
Innovative Medicines Initiative (821283)
- License Information
-
More Information
Article History
Received: 29 March 2023
Accepted: 8 August 2023
First Online: 12 September 2023
Declarations
:
: Ethical approvals were obtained from local ethical review authorities for each of the recruiting locations as listed in Table . Studies are conducted according to the Declaration of Helsinki (Hong Kong Amendment) and Good Clinical Practice (European guidelines) with all participants providing written informed consent or with written informed consent from a personal consultee in specified circumstances when participants lack capacity to give informed consent.
: Not applicable.
: Matthias Hackl is shareholder of TAmiRNA GmbH. Kseniya Khamina-Kotisch is employed by TAmiRNA GmbH. Oliver Poetz is shareholder of SIGNATOPE GmbH. Gerd A. Kullak-Ublick holds Novartis equity. Dingzhou Li, Thi Dong Binh Tran and Shashi K. Ramaiah are employed by Pfizer. Guruprasad P. Aithal has received consulting fees from Pfizer, GlaxoSmithKline, Clinipace, Servier Pharmaceuticals, NUCANA Plc, AstraZeneca and BenevolentAI paid to the University of Nottingham. The other authors declare that they have no competing interests.
